Open Access

ARTICLE

Utility of routine urinalysis and urine culture testing in an ambulatory urology clinic: a quality improvement initiative in a Veterans healthcare facility

Kyle A. Richards^1,2, Stacy Cesario¹, Amy H. Lim¹, Sara L. Best^1,2, Susan M. Deeren¹, Wade Bushman^1,2, Nasia Safdar³

1 Department of Urology, William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin, USA
2 Department of Urology, The University of Wisconsin-Madison, Madison, Wisconsin, USA
3 Department of Medicine, The University of Wisconsin-Madison, Madison, Wisconsin, USA
Address correspondence to Dr. Kyle A. Richards, Dept. of Urology, University of Wisconsin-Madison, 1685 Highland Avenue Madison, WI 53705 USA

Canadian Journal of Urology 2017, 24(1), 8627-8633.

Abstract

Introduction: Urinalysis (UA) and urine culture (UCx) are commonly performed tests in the urology clinic. Many of these urine studies are performed prior to the patient visit may not always be indicated, thus contributing to unintended consequences such as antibiotic use and costs without enhancing patient care. Our objective was to perform a quality improvement initiative aimed to assess the utility of routine UA/UCx.
Materials and methods: The practice pattern at our site's Veteran Affairs (VA) urology clinic prior to 2014 was to obtain routine UA/UCx on most clinic visits prior to patient evaluation. Starting in 2014, we designed an intervention whereby our nurse practitioner triaged all new patient referrals and selectively ordered UA/UCx. We performed multivariable logistic regression to assess for predictors of obtaining UA or UCx.
Results: A total of 1308 patients were seen in January-March 2013 and 1456 in June-August 2014 and were included in this analysis. Fewer patients in 2014 received UA (59.8% versus 70.0%, p < 0.001) and UCx (49.6% versus 64.2%, p < 0.001). There was a decreased odds of obtaining UA in 2014 (OR 0.52, p < 0.001) as well as a decreased odds of obtaining UCx in 2014 (OR 0.38, p < 0.001) on multivariable logistic regression. The results of UA/UCx only rarely resulted in change of management in either cohort (3%). Selective ordering resulted in an estimated cost savings of $4915.08/month in UCx costs alone.
Conclusions: Our quality improvement initiative reduced rates of UA/UCx testing when providers assess patients prior to ordering these tests. The implication of this initiative is significant cost savings for the healthcare system.

---

Keywords

---